FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

The recall only affects the sensor component of the FreeStyle Libre 3 system, which also includes a reader and an app.

Like Dexcom's, each system has smartphone capabilities and data monitoring and sharing applications. Available FreeStyle ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Combine continuous glucose monitoring data from the FreeStyle Libre 2 system, from wherever you are*, along with expert advice from your health coach help you make informed decisions to keep enjoying ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

More than 800 people will be employed at the plant which will be the biggest production centre worldwide for the group’s ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Manage your diabetes with confidence¹ using the FreeStyle Libre 2 system and Gro Health. The FreeStyle Libre 2 system can help improve glycaemic control in type 2 diabetes¹,² along with using Gro ...

Historically, providers would need to log into separate portals or support different workflows for each CGM manufacturer to review the data from their patients. Additionally, it was cumbersome to ...